CL2014000760A1 - Peptido antimicrobiano aislado y purificado de branquias de tilapia (oreochromis niloticus); acido nucleico que lo codifica; composicion que lo comprende; y su uso para el control de patogenos y como adyuvante molecular en una composicion vacunal para aumentar la respuesta inmune contra el antigeno vacunal. - Google Patents
Peptido antimicrobiano aislado y purificado de branquias de tilapia (oreochromis niloticus); acido nucleico que lo codifica; composicion que lo comprende; y su uso para el control de patogenos y como adyuvante molecular en una composicion vacunal para aumentar la respuesta inmune contra el antigeno vacunal.Info
- Publication number
- CL2014000760A1 CL2014000760A1 CL2014000760A CL2014000760A CL2014000760A1 CL 2014000760 A1 CL2014000760 A1 CL 2014000760A1 CL 2014000760 A CL2014000760 A CL 2014000760A CL 2014000760 A CL2014000760 A CL 2014000760A CL 2014000760 A1 CL2014000760 A1 CL 2014000760A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- vaccine
- gills
- tilapia
- pathogens
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 2
- 108700042778 Antimicrobial Peptides Proteins 0.000 title 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 title 1
- 241000276703 Oreochromis niloticus Species 0.000 title 1
- 241000276707 Tilapia Species 0.000 title 1
- 239000002671 adjuvant Substances 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 210000002816 gill Anatomy 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Fodder In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20110181A CU24076B1 (es) | 2011-09-30 | 2011-09-30 | Composición para el control de patógenos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014000760A1 true CL2014000760A1 (es) | 2014-08-22 |
Family
ID=47143463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014000760A CL2014000760A1 (es) | 2011-09-30 | 2014-03-27 | Peptido antimicrobiano aislado y purificado de branquias de tilapia (oreochromis niloticus); acido nucleico que lo codifica; composicion que lo comprende; y su uso para el control de patogenos y como adyuvante molecular en una composicion vacunal para aumentar la respuesta inmune contra el antigeno vacunal. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9549978B2 (enExample) |
| EP (1) | EP2767290B1 (enExample) |
| JP (1) | JP6034385B2 (enExample) |
| KR (1) | KR101986358B1 (enExample) |
| CN (1) | CN103874502B (enExample) |
| AR (1) | AR088176A1 (enExample) |
| AU (1) | AU2012315083B2 (enExample) |
| BR (1) | BR112014007491B1 (enExample) |
| CA (1) | CA2849040C (enExample) |
| CL (1) | CL2014000760A1 (enExample) |
| CU (1) | CU24076B1 (enExample) |
| ES (1) | ES2600903T3 (enExample) |
| MX (1) | MX348934B (enExample) |
| RU (1) | RU2636001C2 (enExample) |
| WO (1) | WO2013044890A1 (enExample) |
| ZA (1) | ZA201402171B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104262485B (zh) * | 2014-04-15 | 2017-01-18 | 四川农业大学 | 罗非鱼sIgM截短重链恒定区蛋白多克隆抗体及其制备方法 |
| CN105061575B (zh) * | 2015-02-03 | 2020-08-04 | 浙江海洋学院 | 一种金枪鱼肝脏抗菌肽及其制备方法和用途 |
| CN109350731A (zh) * | 2018-12-18 | 2019-02-19 | 汕尾市维明生物科技股份有限公司 | 一种罗非鱼蛋白肽在制备免疫制剂中的应用 |
| CN112979763A (zh) * | 2021-03-03 | 2021-06-18 | 山东大学 | 一种基于可溶性疏水载体抗菌肽Oreoch-2的液相合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030056244A1 (en) * | 2000-05-02 | 2003-03-20 | Ning Huang | Feed additive compositions and methods |
| AU2001287179A1 (en) * | 2000-08-15 | 2002-02-25 | North Carolina State University | Antimicrobial peptides isolated from fish |
| US6753407B2 (en) * | 2000-08-15 | 2004-06-22 | North Carolina State University | Antimicrobial peptides isolated from fish |
| WO2004018706A2 (en) * | 2002-08-22 | 2004-03-04 | National Research Council Of Canada | A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| CN101111256B (zh) * | 2004-12-15 | 2012-04-25 | 科罗拉多大学 | 抗菌肽及其使用方法 |
| RU2302467C1 (ru) * | 2005-12-01 | 2007-07-10 | Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук | Пептиды латарцины, проявляющие антимикробную активность |
| US20090186047A1 (en) * | 2006-04-25 | 2009-07-23 | Intercell Ag | HCV Vaccinations |
| TWI299335B (en) | 2006-12-05 | 2008-08-01 | Academia Sinica | Anti-microbal peptides and uses thereof |
| WO2009149554A1 (en) * | 2008-06-11 | 2009-12-17 | National Research Council Of Canada | Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa) |
| CA2745499A1 (en) * | 2008-12-05 | 2010-06-10 | Angiochem Inc. | Peptide therapeutic conjugates and uses thereof |
| US20110039762A1 (en) * | 2009-01-06 | 2011-02-17 | C3 Jian, Inc. | Targeted antimicrobial moieties |
| WO2010091294A2 (en) * | 2009-02-05 | 2010-08-12 | The Regents Of The University Of California | New targeted antimicrobial moieties |
| CN101559214A (zh) * | 2009-05-27 | 2009-10-21 | 珍奥集团股份有限公司 | 具有增强免疫功能作用的组合物及其用途 |
| CN102021172A (zh) * | 2010-06-23 | 2011-04-20 | 广西壮族自治区水产研究所 | 罗非鱼白细胞 cAMP 诱导早期抑制因子基因序列及用途 |
| SG191287A1 (en) * | 2011-01-07 | 2013-07-31 | Valiant Biopharma Sdn Bhd | Antimicrobial fusion compounds and uses thereof |
-
2011
- 2011-09-30 CU CU20110181A patent/CU24076B1/es active IP Right Grant
-
2012
- 2012-09-27 AR ARP120103606A patent/AR088176A1/es unknown
- 2012-10-01 WO PCT/CU2012/000005 patent/WO2013044890A1/es not_active Ceased
- 2012-10-01 KR KR1020147009805A patent/KR101986358B1/ko active Active
- 2012-10-01 CN CN201280050943.4A patent/CN103874502B/zh active Active
- 2012-10-01 EP EP12783080.0A patent/EP2767290B1/en not_active Not-in-force
- 2012-10-01 US US14/346,562 patent/US9549978B2/en active Active
- 2012-10-01 ES ES12783080.0T patent/ES2600903T3/es active Active
- 2012-10-01 JP JP2014532244A patent/JP6034385B2/ja active Active
- 2012-10-01 CA CA2849040A patent/CA2849040C/en active Active
- 2012-10-01 AU AU2012315083A patent/AU2012315083B2/en active Active
- 2012-10-01 MX MX2014003892A patent/MX348934B/es active IP Right Grant
- 2012-10-01 BR BR112014007491-7A patent/BR112014007491B1/pt active IP Right Grant
- 2012-10-01 RU RU2014117659A patent/RU2636001C2/ru active
-
2014
- 2014-03-24 ZA ZA2014/02171A patent/ZA201402171B/en unknown
- 2014-03-27 CL CL2014000760A patent/CL2014000760A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201402171B (en) | 2015-12-23 |
| RU2014117659A (ru) | 2015-11-10 |
| JP6034385B2 (ja) | 2016-11-30 |
| AU2012315083A1 (en) | 2014-05-08 |
| RU2636001C2 (ru) | 2017-11-17 |
| WO2013044890A1 (es) | 2013-04-04 |
| EP2767290A1 (en) | 2014-08-20 |
| CU24076B1 (es) | 2015-01-29 |
| AR088176A1 (es) | 2014-05-14 |
| CA2849040A1 (en) | 2013-04-04 |
| JP2014533931A (ja) | 2014-12-18 |
| BR112014007491B1 (pt) | 2022-03-03 |
| MX348934B (es) | 2017-07-03 |
| CN103874502B (zh) | 2015-11-25 |
| US9549978B2 (en) | 2017-01-24 |
| CA2849040C (en) | 2019-11-26 |
| MX2014003892A (es) | 2014-07-09 |
| KR101986358B1 (ko) | 2019-06-05 |
| AU2012315083B2 (en) | 2016-02-25 |
| EP2767290B1 (en) | 2016-09-14 |
| KR20140070597A (ko) | 2014-06-10 |
| CU20110181A7 (es) | 2013-05-31 |
| ES2600903T3 (es) | 2017-02-13 |
| CN103874502A (zh) | 2014-06-18 |
| US20140294871A1 (en) | 2014-10-02 |
| BR112014007491A2 (pt) | 2017-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014000291A1 (es) | Vacuna que comprende al menos 30 aminoacidos de un polipeptido de p62/sqstm1 o un acido nucleico que lo codifica; y su uso para el tratamiento y profilaxis del cancer. | |
| MX369469B (es) | Vacuna contra el virus respiratorio sincitial. | |
| MX2018012166A (es) | Dosificacion oral de compuestos peptido similar al glaucon-1 (glp-1). | |
| WO2011103453A3 (en) | Vaccines for use in the prophylaxis and treatment of influenza virus disease | |
| CL2014000470A1 (es) | Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana. | |
| BR112016001192A2 (pt) | Vacina contra a raiva | |
| CL2014000370A1 (es) | Hemifumarato de tenofovir alafenamida; metodo de preparación; composicion farmaceutica que lo comprende; metodo para preparar la composicion farmaceutica; y uso en el tratamiento de una infeccion por hiv. | |
| EP2753345A4 (en) | POLYPEPTIDIMPFSTOFF | |
| MX359954B (es) | Ácido nucleico que comprende o codifica para un asa troncal de histona y una secuencia poly (a) o una señal de poliadenilación para aumentar la expresión de un antígeno patogénico codificado. | |
| CL2014002093A1 (es) | Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas. | |
| EP2720717C0 (en) | VACCINE ADJUVANT COMPOSITION COMPRISING INULIN PARTICLES | |
| CL2013001947A1 (es) | Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona. | |
| PT3089754T (pt) | Formulações de vacina de dose única | |
| WO2013132041A3 (en) | Adjuvanted formulations of booster vaccines | |
| EP2825196A4 (en) | ADJUVANZ AND VACCINE COMPOSITIONS | |
| CO2017006898A2 (es) | Formulación de relación fija de insulina glargina/lixisenatida | |
| CL2012002016A1 (es) | Vector para vacunas que comprende un polipeptido antigénico y un polipéptido hmgb1 o un fragmento funcional; composición que comprende el vector; método para potenciar respuesta inmune en un sujeto. | |
| CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
| EP2755680A4 (en) | PARTICULATE VACCINE FORMULATIONS | |
| CL2014003012A1 (es) | Formulación en capsulas que comprende al menos un compuesto de formula (i), solubilizado; metodo de administracion de la formulacion; uso para tratar una infeccion por el virus de la hepatitis c. | |
| MD20120127A2 (en) | Recombinant Koi herpesvirus (KHV), method for its production and vaccine for the prevention of a disease caused by KHV | |
| BR112015002549A2 (pt) | regime de vacinação para proteger uma criança contra infecção ou doença causada por vírus sincicial respiratório, composição imunogênica ou pluralidade de composições imunogênicas, uso de uma composição imunogênica ou de uma pluralidade de composições imunogênicas | |
| BR112013031575A2 (pt) | composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto. | |
| DK2709656T3 (da) | Proteinmatrix-vaccinesammensætninger omfattende polykationer | |
| CL2014000760A1 (es) | Peptido antimicrobiano aislado y purificado de branquias de tilapia (oreochromis niloticus); acido nucleico que lo codifica; composicion que lo comprende; y su uso para el control de patogenos y como adyuvante molecular en una composicion vacunal para aumentar la respuesta inmune contra el antigeno vacunal. |